Matthew Paul Larson, Slide Insurance Holdings' chief risk officer, completed the sale of 11,250 shares of the insurer's common stock on April 6, 2026, at $18.00 per share, producing gross proceeds of $202,500. The transaction was disclosed in a Form 4 filed with the Securities and Exchange Commission and was carried out pursuant to a 10b5-1 trading plan originally adopted on December 4, 2025.
On the same calendar day Larson exercised options to acquire an equal number of shares - 11,250 - at an exercise price of $0.79 per share, for a total option exercise cost of $8,887. After the sale, the Form 4 shows Larson holds zero shares of Slide Insurance Holdings directly.
The sale occurred against a valuation backdrop noted by InvestingPro, which the filing cites as indicating the stock is currently undervalued based on its Fair Value assessment. The company’s reported fundamentals remain strong: Slide Insurance carries a market capitalization of $2.23 billion and receives an overall financial health score rated as "GREAT" by InvestingPro.
Slide Insurance's recent operational and capital-deployment activity reinforces that picture. In fourth-quarter 2025 results the company reported earnings per share of $1.23 versus analyst expectations of $0.71, and revenue rose to $347 million from $238.5 million year-over-year. The company also completed a previously announced $120 million stock repurchase program and has authorized an additional $125 million buyback initiative.
Broker commentary accompanying the results has been broadly favorable. Barclays reiterated an Overweight rating on Slide Insurance with a $29 price target. Texas Capital Securities commenced coverage with a Buy rating and a $25 price target. Keefe, Bruyette & Woods adjusted its price target to $23, citing the strong fourth-quarter results and continuing positive trends.
The transaction by Larson, executed under a pre-established trading plan and coupled with simultaneous option exercises, leaves him with no direct share ownership while the company itself pursues buybacks and benefits from upward analyst revisions following the quarter. The public filings and company disclosures detail the mechanics and timing of the insider activity and provide the financial metrics cited above.
Clear summary
Slide Insurance CRO Matthew Paul Larson sold 11,250 shares on April 6, 2026, at $18.00 per share pursuant to a 10b5-1 plan adopted December 4, 2025, and exercised 11,250 options at $0.79 per share the same day. Following the sale he holds no direct shares. Slide reported stronger-than-expected fourth-quarter 2025 results, raised buyback authorizations, and received multiple positive analyst price-targets.
Key points
- Insider transaction - Matthew Larson sold 11,250 Slide Insurance shares at $18.00 on April 6, 2026, and exercised 11,250 options at $0.79 the same day; after the sale he directly owns zero shares.
- Company fundamentals and capital returns - Slide Insurance has a $2.23 billion market capitalization, a "GREAT" financial health score from InvestingPro, posted Q4 2025 EPS of $1.23 versus $0.71 expected, and revenue of $347 million versus $238.5 million a year earlier; the company completed a $120 million repurchase program and authorized a new $125 million buyback.
- Analyst stance - Barclays reiterated an Overweight rating with a $29 target, Texas Capital Securities initiated coverage at Buy with a $25 target, and Keefe, Bruyette & Woods set a $23 target following strong quarterly results.
Risks and uncertainties
- Insider disposition - The sale leaves the named insider with no direct ownership in Slide Insurance, which could raise questions for some investors about insider alignment; this impacts investor perception in the financials and insurance sectors.
- Valuation divergence - InvestingPro's Fair Value assessment suggests the stock is undervalued while an insider executed a sale; the differing signals create valuation uncertainty that market participants will need to reconcile in the insurance and broader equity markets.
- Dependence on disclosures - The public record here rests on the Form 4 filing and company-reported quarter-to-quarter metrics; any further interpretation beyond the filings is limited by the available disclosures.
Note: All transaction details, financial metrics, analyst ratings, and program amounts referenced above are drawn from the company's filings and disclosed reports.